Technology surveillance in veterinary vaccine adjuvants (2015-2022): University-industry interaction

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorGrupo Empresarial LABIOFAM-
Autor(es): dc.contributorUniversidad de Ciencias Médicas de La Habana-
Autor(es): dc.contributorUniversidade Estadual Paulista (UNESP)-
Autor(es): dc.contributorAnimal Science Research Group Universidad Cooperativa de Colombia sede Bucaramanga-
Autor(es): dc.creatorDomínguez-Odio, Aníbal-
Autor(es): dc.creatorPérez, Oliver-
Autor(es): dc.creatorBatista-Duharte, Alexander-
Autor(es): dc.creatorCala-Delgado, Daniel Leonardo-
Data de aceite: dc.date.accessioned2025-08-21T22:51:08Z-
Data de disponibilização: dc.date.available2025-08-21T22:51:08Z-
Data de envio: dc.date.issued2023-07-29-
Data de envio: dc.date.issued2023-07-29-
Data de envio: dc.date.issued2022-09-01-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.56499/jppres22.1430_10.5.875-
Fonte completa do material: dc.identifierhttp://hdl.handle.net/11449/247694-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/247694-
Descrição: dc.descriptionContext: The new generation of immunoenhancers will have to offer solutions to each clinical and technological limitation that currently exists. This innovative context requires periodic technological surveillance by the veterinary biopharmaceutical industry to anticipate technological changes and predict future competitive advantages. Aims: To evaluate the current status, scientific trends, and technological projections in the use of veterinary immunological adjuvants for productive and companion species in the period 2015 and 2021. Methods: The bibliometric analysis included scientific articles on adjuvants in veterinary medicine published in English in 2015–2021 and indexed on the Scopus and Web of Science platforms. All relevant records retrieved between 2015 and 2022 were grouped using the EndNote bibliographic manager, while the analysis of the relational metric indicator was performed and viewed by VOSviewer®. Instead, data on the main commercial veterinary vaccine adjuvants in 2022 were collected from the official websites of 20 veterinary vaccine manufacturers with experience in the market. Results: The academy dedicated 68.2% of its production to disseminating articles with original experimental results with 73.6% being novel notifications about adjuvants of natural, microbial and nanotechnological origin. Industrial production mainly used monoadjuvation (86.9%), inorganic salts adjuvants (48.1%), particularly aluminum hydroxide (43.0%), and classical technology (89.2%) to produce their commercial formulations. Ruminants, swines, and poultry dominated both sectors, with ruminants being the main protagonist. Conclusions: The new scientific knowledge will not have a significant impact on the veterinary pharmaceutical industry in the short term and the hegemonic continuity of traditional adjuvants, in particular aluminum hydroxide, is expected.-
Descrição: dc.descriptionDirección de Investigación e Innovación Grupo Empresarial LABIOFAM, Avenida Independencia Km 16 ½ Boyeros-
Descrição: dc.descriptionInstituto de Ciencias Básicas y Preclínicas “Victoria de Girón” Universidad de Ciencias Médicas de La Habana-
Descrição: dc.descriptionLaboratório de Imunología Clínica. Dpto Analises Clinicas. Faculdade de Ciências Farmacêuticas Univesidade Estadual Paulista (UNESP), Rod. Araraquara-Jaú, Km 1, Campus Ville Arara-quara-
Descrição: dc.descriptionAnimal Science Research Group Universidad Cooperativa de Colombia sede Bucaramanga, Carrera 33 N°. 30A–05. Zip Code 68000-
Descrição: dc.descriptionLaboratório de Imunología Clínica. Dpto Analises Clinicas. Faculdade de Ciências Farmacêuticas Univesidade Estadual Paulista (UNESP), Rod. Araraquara-Jaú, Km 1, Campus Ville Arara-quara-
Formato: dc.format875-887-
Idioma: dc.languageen-
Relação: dc.relationJournal of Pharmacy and Pharmacognosy Research-
???dc.source???: dc.sourceScopus-
Palavras-chave: dc.subjectadjuvant-
Palavras-chave: dc.subjectimmunoprophylaxis-
Palavras-chave: dc.subjecttechnological surveillance-
Palavras-chave: dc.subjectveterinary vaccine-
Título: dc.titleTechnology surveillance in veterinary vaccine adjuvants (2015-2022): University-industry interaction-
Título: dc.titleVigilancia tecnológica en adyuvantes de vacunas veterinarias (2015-2022): Interacción universidad-industria-
Tipo de arquivo: dc.typevídeo-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.